About the Authors
- Caroline L Smith
-
*To whom correspondence should be addressed. E-mail: c.l.smith@ucl.ac.uk
Affiliation Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom
- Shelagh Anthony
-
Affiliation Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom
- Mike Hubank
-
Affiliation Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom
- James M Leiper
-
Affiliation Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom
- Patrick Vallance
-
Affiliation Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom
Competing Interests
University College London holds patents on DDAH as a drug target (not relevant to the present study).
Author Contributions
CLS, JML, and PV designed the study. CLS, SA, MH, JML, and PV analyzed the data. CLS, MH, JML, and PV contributed to writing the paper.